Delivery Order SPE2DB24D1205-SPE2DB24FCREF

Award Date 5/9/24
Potential Completion Date 5/10/24
Potential Value $5K
Ultimate Awardee
Cencora, Inc.
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, with an award ID of SPE2DX15D3504|SPE2DX24F03E8, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract, valued at $3,621.83, is for the delivery of 1,000 tablets of Glipizide ER 10 mg, a medication used in the management of diabetes. The contract is a Firm Fixed Price Delivery Order with an ultimate completion date of January 26, 2024. This award is not designated as a...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., for the supply of Glipizide ER 10 mg tablets. The contract has a total ceiling value of $4,261.23 and an ultimate completion date of May 6, 2024. It is a firm fixed-price contract with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that has established itself as a key vendor for federal...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The award, valued at $9,070.23, is for the delivery of 4563525433 - Glimepiride 4 mg tablets in quantities of 100s. The contract is a firm fixed-price delivery order with a completion date of February 5, 2024. This award is not designated as a set-aside and was made through full and open competition. Amerisourcebergen Drug Corp, a...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order valued at $9,832.48 for the supply of 4 mg Glimepiride tablets. The award was made by the Defense Logistics Agency (DLA) Troop Support Medical, a component of the Department of Defense, and does not have a set-aside designation. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00, which serves as...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a Delivery Order valued at $13,035.05 for the supply of 4 mg glimepiride tablets to the Defense Logistics Agency (DLA) Troop Support Medical. The contract has an ultimate completion date of December 6, 2023 and is a Firm Fixed Price arrangement. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00 and running through...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $1,204.75 delivery order contract is for the supply of the pharmaceutical drug Glimepiride 1 mg tablets. The contract is a Firm Fixed Price Delivery Order with a completion date of January 12, 2024. This award is not associated with a set-aside designation, indicating it was competed on an open market. Amerisourcebergen Drug Corp is a major pharmaceutical...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is for the delivery of Glimepiride 1 mg tablets to support the Defense Logistics Agency (DLA) Troop Support Medical program. The $2,011.03 Firm Fixed Price delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 held by Cencora, Inc. with the DLA. This single-award IDC serves as the primary vehicle for Cencora, Inc. to supply a comprehensive range of...
This contract award to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc., is a delivery order worth $2,683.53 for the supply of Glimepiride 4 mg tablets to the Defense Logistics Agency (DLA). The award, which has an ultimate completion date of December 28, 2023, is issued under a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that Cencora, Inc. holds with the DLA Troop Support Medical. This IDC serves as the primary vehicle for Cencora, Inc....
This federal contract award, valued at $14,004.66, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is a delivery order for the supply of GLIMEPIRIDE 4 MG TABLET 100S, a pharmaceutical product. The award is part of a larger Indefinite Delivery Contract (IDC) between the DLA Troop Support Medical and Cencora, Inc., valued at up to $999,999,999.00 and running through November 2026. This IDC serves as...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract, valued at $2,018.59, is for the delivery of 4,564,559,699 units of the pharmaceutical product GLIMEPIRIDE 4 MG TABLET 100S. This is a firm fixed-price delivery order with a completion date of May 10, 2024. The contract has no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a major...
  • SPE2DB24D1205
    Indefinite Delivery Contract
  • SPE2DB24D1205-SPE2DB24FCREF
    Delivery Order

This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $4,974.55 firm-fixed-price delivery order is for the supply of 1,000 units of Glipizide ER 10 mg tablets. The award has a completion date of May 10, 2024.

Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the company to provide a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. Additionally, Cencora, Inc. maintains a separate $750,000 IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs. These IDCs enable efficient government procurement of essential pharmaceutical and medical supplies for military personnel, veterans, and other federal beneficiaries. The contract award reviewed does not have a set-aside designation, indicating open competition.

Generated 5/16/25, 11:46 AM